Virtus ETF Advisers LLC Reata Pharmaceuticals Inc Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$79.22 - $105.37 $38,659 - $51,420	488 Added 16.98%	3,362 $342,000
Q1 2023 May 15, 2023	SELL	$30.85 - $93.17 $33,965 - $102,580	-1,101 Reduced 27.7%	2,874 $261,000
Q4 2022 Feb 14, 2023	BUY	$22.15 - $42.11 $8,217 - $15,622	371 Added 10.29%	3,975 $151,000
Q3 2022 Nov 14, 2022	BUY	$19.41 - $36.49 $485 - $912	25 Added 0.7%	3,604 $91,000
Q2 2022 Aug 12, 2022	SELL	$20.71 - $36.5 $36,967 - $65,152	-1,785 Reduced 33.28%	3,579 $109,000
Q1 2022 May 16, 2022	SELL	$24.12 - $39.6 $7,718 - $12,672	-320 Reduced 5.63%	5,364 $176,000
Q4 2021 Feb 14, 2022	BUY	$25.61 - $110.96 $107,510 - $465,810	4,198 Added 282.5%	5,684 $150,000
Q3 2021 Nov 15, 2021	SELL	$100.0 - $143.02 $7,400 - $10,583	-74 Reduced 4.74%	1,486 $150,000
Q2 2021 Aug 10, 2021	SELL	$78.27 - $151.29 $76,469 - $147,810	-977 Reduced 38.51%	1,560 $221,000
Q1 2021 May 17, 2021	BUY	$94.25 - $132.81 $3,675 - $5,179	39 Added 1.56%	2,537 $253,000
Q4 2020 Feb 12, 2021	BUY	$102.03 - $184.62 $61,728 - $111,695	605 Added 31.96%	2,498 $309,000
Q3 2020 Nov 13, 2020	SELL	$93.53 - $163.34 $23,663 - $41,325	-253 Reduced 11.79%	1,893 $184,000
Q2 2020 Aug 05, 2020	BUY	$126.3 - $176.56 $51,530 - $72,036	408 Added 23.48%	2,146 $335,000
Q1 2020 May 14, 2020	SELL	$124.16 - $247.74 $31,536 - $62,925	-254 Reduced 12.75%	1,738 $251,000
Q4 2019 Feb 13, 2020	SELL	$74.57 - $217.92 $82,698 - $241,673	-1,109 Reduced 35.76%	1,992 $407,000
Q3 2019 Nov 12, 2019	SELL	$71.26 - $95.75 $12,256 - $16,469	-172 Reduced 5.26%	3,101 $249,000
Q2 2019 Aug 13, 2019	SELL	$77.72 - $94.35 $87,279 - $105,955	-1,123 Reduced 25.55%	3,273 $309,000
Q1 2019 May 14, 2019	SELL	$51.9 - $101.79 $29,064 - $57,002	-560 Reduced 11.3%	4,396 $376,000
Q4 2018 Feb 05, 2019	SELL	$48.76 - $76.44 $340,491 - $533,780	-6,983 Reduced 58.49%	4,956 $278,000
Q3 2018 Nov 14, 2018	SELL	$35.64 - $92.06 $304,543 - $786,652	-8,545 Reduced 41.72%	11,939 $976,000
Q2 2018 Aug 10, 2018	SELL	$19.94 - $40.96 $191,503 - $393,379	-9,604 Reduced 31.92%	20,484 $716,000
Q1 2018 May 14, 2018	BUY	$20.0 - $30.19 $323,420 - $488,202	16,171 Added 116.2%	30,088 $617,000
Q4 2017 Feb 14, 2018	BUY	$22.39 - $33.27 $22,210 - $33,003	992 Added 7.68%	13,917 $394,000
Q3 2017 Nov 14, 2017	BUY	$26.29 - $31.88 $31,074 - $37,682	1,182 Added 10.07%	12,925 $402,000
Q2 2017 Aug 14, 2017	BUY	N/A	11,743	11,743 $372,000

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account